Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lodo Therapeutics
New York, New York, United Statesacceleratorlsp.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Lodo Therapeutics developed a proprietary genomics and AI-driven platform to mine microbial DNA for structurally diverse natural products, aiming to address previously undruggable targets for infectious disease, immunology, and oncology. It was acquired preclinical, with public output focused on platform demonstrations and strategic partnerships, rather than clinical results[1][2][4].
- Therapeutic areas
- Infectious DiseasesOncologyImmunology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
The Rockefeller University[1]Bill & Melinda Gates Foundation[1][2]ARCH Venture Partners[2]AbbVie Ventures[2]Alexandria Venture Investments[2]
Beyond the preview
Go deeper on Lodo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lodo Therapeutics.